Subcutaneous Enoxaparin for Therapeutic Anticoagulation in Hemodialysis Patients

MLA

William E. Dager, et al. “Subcutaneous Enoxaparin for Therapeutic Anticoagulation in Hemodialysis Patients.” Thrombosis Research, vol. 133, June 2014, pp. 1023–28. EBSCOhost, https://doi.org/10.1016/j.thromres.2014.03.036.

APA

William E. Dager, A. Joshua Roberts, Tiffany K. Pon, & Richard H. White. (2014). Subcutaneous Enoxaparin for Therapeutic Anticoagulation in Hemodialysis Patients. Thrombosis Research, 133, 1023–1028. https://doi.org/10.1016/j.thromres.2014.03.036

Chicago

William E. Dager, A. Joshua Roberts, Tiffany K. Pon, and Richard H. White. 2014. “Subcutaneous Enoxaparin for Therapeutic Anticoagulation in Hemodialysis Patients.” Thrombosis Research 133 (June): 1023–28. doi:10.1016/j.thromres.2014.03.036.